Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy

Objectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. Th...

Full description

Bibliographic Details
Main Authors: Jorge Cea Garcia, Antonio Jiménez Caraballo, MarÍa del Mar Rios Vallejo, Ignacio Zapardiel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Gynecology and Minimally Invasive Therapy
Subjects:
Online Access:http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Cea
_version_ 1819017572819927040
author Jorge Cea Garcia
Antonio Jiménez Caraballo
MarÍa del Mar Rios Vallejo
Ignacio Zapardiel
author_facet Jorge Cea Garcia
Antonio Jiménez Caraballo
MarÍa del Mar Rios Vallejo
Ignacio Zapardiel
author_sort Jorge Cea Garcia
collection DOAJ
description Objectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. This study aims to estimate the rate of symptomatic recurrence following hysteroscopic polypectomy and to analyze the possible risk factors involved with Versapoint® versus resectoscope. Materials and Methods: We designed a retrospective cohort study in a tertiary university hospital in Seville (Spain) which looked at the results of polypectomy with a 9-mm resectoscope on 42 women between 2008 and 2015 compared to 151 women using Versapoint® during 2014. Results: The rate of first recurrence was 24.35%. There was a strong positive correlation between the recurrence and the follow-up duration (odds ratio [OR] = 2.58; 95% confidence interval [CI] = 1.68–5.04; P = 0.000), the polyps causing abnormal uterine bleeding (OR = 2.5; 95% CI: 1.1–3; P = 0.04), and a polyp size >15 mm (OR = 1.63; 95% CI = 1.3–3.1; P = 0.02). There were no statistical differences in polyps' recurrence among the types of hysteroscopic polypectomy (P > 0.05). Conclusion: The main risk factors for recurrence were polyps causing abnormal uterine bleeding, size, and follow-up duration.
first_indexed 2024-12-21T03:05:40Z
format Article
id doaj.art-1d04562a87e44d139369953e2b708942
institution Directory Open Access Journal
issn 2213-3070
language English
last_indexed 2024-12-21T03:05:40Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Gynecology and Minimally Invasive Therapy
spelling doaj.art-1d04562a87e44d139369953e2b7089422022-12-21T19:18:05ZengWolters Kluwer Medknow PublicationsGynecology and Minimally Invasive Therapy2213-30702020-01-019420921410.4103/GMIT.GMIT_102_19Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomyJorge Cea GarciaAntonio Jiménez CaraballoMarÍa del Mar Rios VallejoIgnacio ZapardielObjectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. This study aims to estimate the rate of symptomatic recurrence following hysteroscopic polypectomy and to analyze the possible risk factors involved with Versapoint® versus resectoscope. Materials and Methods: We designed a retrospective cohort study in a tertiary university hospital in Seville (Spain) which looked at the results of polypectomy with a 9-mm resectoscope on 42 women between 2008 and 2015 compared to 151 women using Versapoint® during 2014. Results: The rate of first recurrence was 24.35%. There was a strong positive correlation between the recurrence and the follow-up duration (odds ratio [OR] = 2.58; 95% confidence interval [CI] = 1.68–5.04; P = 0.000), the polyps causing abnormal uterine bleeding (OR = 2.5; 95% CI: 1.1–3; P = 0.04), and a polyp size >15 mm (OR = 1.63; 95% CI = 1.3–3.1; P = 0.02). There were no statistical differences in polyps' recurrence among the types of hysteroscopic polypectomy (P > 0.05). Conclusion: The main risk factors for recurrence were polyps causing abnormal uterine bleeding, size, and follow-up duration.http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Ceaendometriumhysteroscopypolyprecurrencerisk factors
spellingShingle Jorge Cea Garcia
Antonio Jiménez Caraballo
MarÍa del Mar Rios Vallejo
Ignacio Zapardiel
Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
Gynecology and Minimally Invasive Therapy
endometrium
hysteroscopy
polyp
recurrence
risk factors
title Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
title_full Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
title_fullStr Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
title_full_unstemmed Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
title_short Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
title_sort retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
topic endometrium
hysteroscopy
polyp
recurrence
risk factors
url http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Cea
work_keys_str_mv AT jorgeceagarcia retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy
AT antoniojimenezcaraballo retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy
AT mariadelmarriosvallejo retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy
AT ignaciozapardiel retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy